Eleonora Ottina

Eleonora obtained a PhD in Immunology at the Innsbruck Medical University where she studied the role of apoptosis in the development and activation of the immune system. She is a PostDoc at the Francis Crick Institute where she continues to work in immunology and oncology investigating the mechanisms regulating the adaptive immunity to cancer. The prospect of effective immunotherapies for the treatment of cancer patients is now becoming a clinical reality, however the major challenge lies in the molecular identification of tumour-associated antigens. The work Eleonora is currently doing in murine cancer models will provide insight whether endogenous retrovirus products could elicit an anti-tumour immunity that could be exploited for therapeutic intervention